The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNNN.L Regulatory News (NNN)

  • There is currently no data for NNN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

24 May 2023 14:27

RNS Number : 5469A
Nanosynth Group PLC
24 May 2023
 

24 May 2023

 

nanosynth group plc

("nanosynth", the "Company" or the "Group")

 

Notice of General Meeting

 

Further to its announcement on 16 May 2023, regarding the Company's proposal to appoint liquidators, the board of nanosynth ("Board") has resolved that a general meeting of the Members of the Company be convened ("General Meeting"), to be held at FinnCap, 1 Bartholomew Cl, London EC1A 7BL at 10.00 a.m. on 15 June 2023. The purpose of the General Meeting is to consider, and if thought fit, pass the following resolutions, number 1 as a Special resolution and number 2, as an Ordinary resolution:

 

Resolutions

 

1.

"That the Company be wound up voluntarily";

2.

"That Simon Jagger and Cameron Gunn of ReSolve Advisory Limited, 22 York Buildings, London WC2N 6JU, be appointed as Joint Liquidators of the Company and that they be authorised to act either jointly or separately"; and

3.

"That the admission of the Company's shares to trading on AIM be cancelled ("Cancellation") with such cancellation expected to become effective on 26 June 2023". This resolution is conditional on the passing of resolutions one and two."

 

A circular convening the General Meeting can be viewed here: http://www.rns-pdf.londonstockexchange.com/rns/5469A_1-2023-5-24.pdf

Shareholders should note that the Cancellation resolution is being sought as the Company is expected to be in the process of being wound up. As stated in the Company's announcement on 16 May 2023, the board of the Company has determined that potential funding options available are unlikely to come to fruition within the required timeframe and that the only available course of action in order to protect creditors is to commence the insolvent liquidation of the Company. Due to the winding up the board does not intend to establish a facility whereby shareholders may effect transactions in the Company's shares following the Cancellation.

The Board notes that, if the special resolution to wind up the Company is not passed, then the Directors will need to consider whether, given the insolvent position of the Company, it is appropriate to make an application to Court for the compulsory winding-up of the Company.

As previously notified, upon the appointment of liquidators, the Company's nominated adviser will step down with immediate effect.

All enquiries relating to the liquidation process should now be made directly to ReSolve Advisory Limited.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

 

ENQUIRIES:

 

ReSolve Advisory Limited (Prospective liquidator)

Simon Jagger

Cameron Gunn

 

nanosynth@resolvegroupuk.com

nanosynth group plc

Mark Duffin (Chief Executive Officer)

 

via IFC Advisory

IFC Advisory Ltd

Graham Herring

Zach Cohen

 

+44 20 3934 6630

Nominated Adviser and Broker

Stuart Gledhill

Kasia Brzozowska

+44 20 3470 0470

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGFLFFVEVISFIV
Date   Source Headline
17th Nov 20237:00 amRNSCancellation - Nanosynth Group PLC
14th Nov 20234:10 pmRNSCompany Insolvency
29th Sep 20237:00 amRNSAccounts Update
30th Aug 20233:30 pmRNSAppointment of Joint Broker
30th Aug 20237:00 amRNSResignation of Finance Director
28th Jul 20233:53 pmRNSResignation of Chief Executive Officer
26th Jun 202311:24 amRNSAccounts Update
14th Jun 20233:27 pmRNSNotice re. General Meeting
24th May 20232:27 pmRNSNotice of General Meeting
16th May 202312:28 pmRNSProposal to Appoint Liquidators
16th May 202312:03 pmRNSSuspension - Nanosynth Group plc
28th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20233:05 pmRNSFinancial Position
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20233:42 pmRNSDirectorate Change
20th Jan 202310:48 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSCorporate and Commercial Update
10th Jan 20237:00 amRNSPlacing and Subscription to raise £0.4 million
4th Jan 20232:56 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Report
6th Sep 20224:47 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20224:41 pmRNSSecond Price Monitoring Extn
31st Aug 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20222:05 pmRNSSecond Price Monitoring Extn
31st Aug 20222:00 pmRNSPrice Monitoring Extension
31st Aug 202211:05 amRNSSecond Price Monitoring Extn
31st Aug 202211:00 amRNSPrice Monitoring Extension
31st Aug 20229:05 amRNSSecond Price Monitoring Extn
31st Aug 20229:00 amRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSSuccessful Trial Results
30th Aug 20227:00 amRNSJoint Development Agreement in Cosmetics Market
26th Aug 20227:00 amRNSLanstead Subscription and Sharing Agreement
1st Aug 20222:05 pmRNSSecond Price Monitoring Extn
1st Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20221:08 pmRNSPDMR Dealings
26th Jul 20222:41 pmRNSResult of AGM
12th Jul 202211:06 amRNSSecond Price Monitoring Extn
12th Jul 202211:00 amRNSPrice Monitoring Extension
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
11th Jul 20224:40 pmRNSSecond Price Monitoring Extn
11th Jul 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
11th Jul 202210:30 amRNSDirector/PDMR dealings
6th Jul 20229:00 amRNSPrice Monitoring Extension
5th Jul 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.